Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Dmitri V Krysko"'
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTFerroptosis has gained interest due to it immunogenicity and the higher sensitivity of cancer cells to it. However, it was recently shown that ferroptosis in tumor-associated neutrophils leads to immunosuppression and negatively impacts thera
Externí odkaz:
https://doaj.org/article/6888e711856c47f189e1067496d2f993
Autor:
Iuliia Efimova, Elena Catanzaro, Louis Van der Meeren, Victoria D Turubanova, Hamida Hammad, Tatiana A Mishchenko, Maria V Vedunova, Carmela Fimognari, Claus Bachert, Frauke Coppieters, Steve Lefever, Andre G Skirtach, Olga Krysko, Dmitri V Krysko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Immunotherapy represents the future of clinical cancer treatment. The type of cancer cell death determines the antitumor immune response and thereby contributes to the efficacy of anticancer therapy and long-term survival of patients. Indu
Externí odkaz:
https://doaj.org/article/2a503d3f5540469a8ba20ba437a6ab07
Autor:
Abhishek D Garg, Lorenzo eGalluzzi, Lionel eApetoh, Thais eBaert, Raymond B Birge, Jose Manuel Bravo-San Pedro, Karine eBreckpot, David eBrough, Ricardo eChaurio, Mara eCirone, An eCoosemans, Pierre G Coulie, Dirk eDe Ruysscher, Luciana eDini, Peter ede Witte, Aleksandra M Dudek-Peric, Alberto eFaggioni, Jitka eFucikova, Udo S Gaipl, Jakub eGolab, Marie-Lise eGougeon, Michael R Hamblin, Akseli eHemminki, Martin eHerrmann, James W. Hodge, Oliver eKepp, Guido eKroemer, Dmitri V Krysko, Walter G Land, Frank eMadeo, Angelo A. Manfredi, Stephen R. Mattarollo, Christian eMaueroder, Nicolò eMerendino, Gabriele eMulthoff, Thomas ePabst, Jean-Ehrland eRicci, Chiara eRiganti, Erminia eRomano, Nicole eRufo, Mark J. Smyth, Jürgen eSonnemann, Radek eSpisek, John eStagg, Erika eVacchelli, Peter eVandenabeele, Lien eVandenberk, Benoit J Van Den Eynde, Stefaan Willy Van Gool, Francesca eVelotti, Laurence eZitvogel, Patrizia eAgostinis
Publikováno v:
Frontiers in Immunology, Vol 6 (2015)
The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens including dendritic cell-based vaccines, checkpoint-blocking ther
Externí odkaz:
https://doaj.org/article/570f706e67a046259f12244a30e66c60
Autor:
Gizem Ayna, Dmitri V Krysko, Agnieszka Kaczmarek, Goran Petrovski, Peter Vandenabeele, László Fésüs
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e40069 (2012)
Pathogen-activated and damage-associated molecular patterns activate the inflammasome in macrophages. We report that mouse macrophages release IL-1β while co-incubated with pro-B (Ba/F3) cells dying, as a result of IL-3 withdrawal, by apoptosis with
Externí odkaz:
https://doaj.org/article/8afcc4da8a7942c590266210ad0ccb95
Autor:
Elena Catanzaro, Eleonora Turrini, Tessa Kerre, Simon Sioen, Ans Baeyens, Alessandra Guerrini, Mohamed Lamin Abdi Bellau, Gianni Sacchetti, Guglielmo Paganetto, Dmitri V. Krysko, Carmela Fimognari
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 154, Iss , Pp 113662- (2022)
Ferroptosis induction is an emerging strategy to treat cancer and contrast the tricky issue of chemoresistance, which can arise towards apoptosis. This work elucidates the anticancer mechanisms evoked by perillaldehyde, a monoterpenoid isolated from
Externí odkaz:
https://doaj.org/article/79769f266e7c4fe381783b5016eeade1
Publikováno v:
CELL PROLIFERATION
In recent years, the importance of the investigation of regulated cell death (RCD) has significantly increased and different methods are proposed for the detection of RCD including biochemical as well as fluorescence assays. Researchers have shown th
Autor:
Maria Vedunova, Victoria Turubanova, Olga Vershinina, Maria Savyuk, Iuliia Efimova, Tatiana Mishchenko, Robrecht Raedt, Anne Vral, Christian Vanhove, Daria Korsakova, Claus Bachert, Frauke Coppieters, Patrizia Agostinis, Abhishek D. Garg, Mikhail Ivanchenko, Olga Krysko, Dmitri V. Krysko
Publikováno v:
CELL DEATH & DISEASE
Gliomas, the most frequent type of primary tumor of the central nervous system in adults, results in significant morbidity and mortality. Despite the development of novel, complex, multidisciplinary, and targeted therapies, glioma therapy has not pro
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-10 (2021)
CELL DEATH DISCOVERY
Cell Death Discovery
CELL DEATH DISCOVERY
Cell Death Discovery
Regulated cell death modalities such as apoptosis and necroptosis play an important role in regulating different cellular processes. Currently, regulated cell death is identified using the golden standard techniques such as fluorescence microscopy an
Autor:
Tatiana A. Mishchenko, Irina V. Balalaeva, Maria O. Klimenko, Anna A. Brilkina, Nina N. Peskova, Evgenii L. Guryev, Dmitri V. Krysko, Maria V. Vedunova
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3822
CANCERS
CANCERS
Simple Summary The creation of stable fluorescent glioma cell lines opens prospects for the detailed characterization of the molecular mechanisms of glioma origin and pathogenesis, and the development of breakthrough therapeutic approaches to achieve
Publikováno v:
Trends in Cancer. 7:484-487
Photodynamic therapy (PDT) is widely used in cancer treatment; however, several challenges compromise its efficiency. We propose a synergistic action between PDT and ferroptotic cell death. PDT acts as a source of reactive oxygen species for the Fent